Skip to main content

Table 1 Patient Clinical Characteristics

From: Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma

 

Subgroup

Number

Age at Diagnosis

<40 year

2

>40 year

8

Median

46 years (35–62 years)

Tumour Site

Frontal

4

Parietal

3

Temporal

1

Occipital

2

Pathology

AOD

4

AOA

6

FDG Uptake

Nil

3

Positive

7

Gad enhancement

Nil

6

Positive

4

Tumour Volume High Risk (PTVhr)

Median Range

25.5 cm3 (7.0–142.1 cm3)

Tumour Volume Standard Risk (PTVsr)

Median Range

300.0 cm3 (119.2–618.1 cm3)

Tumour Volume Ratio of High to Low Risk (PTVhr/PTVsr)

Median Range

11.5% (3.2–46.4%)